Will Covid-19 kill the high street once and for all?
University of SheffieldThe shift to home working during Covid-19, or ‘Zoomshock’, threatens the survival of local goods and services provided in city centres and business parks
Related Expert Pitches
Filters close
Showing results
11–20 of 4573
Released: 15-Jan-2021 11:20 AM EST
14-Jan-2021 5:00 PM EST
AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health
Association of American Cancer Institutes (AACI)AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.
Released: 15-Jan-2021 8:55 AM EST
The First Dose of the Pfizer Vaccine Gives About 50% COVID Protection, Not 91% Claimed by Those Who Want to Speed Up Immunization
NewswiseThe NEJM paper actually states that the efficacy between the first and second doses was found to be 52 percent when given 21 days apart. After the second dose, the efficacy raises to 95 percent.
Released: 15-Jan-2021 8:20 AM EST
Houston Methodist study finds males of all ages more affected by COVID-19 than females
Houston MethodistA new Houston Methodist study found males are more likely to test positive for COVID-19, have complications and die from the virus than females, independent of age. The peer-reviewed observational study appears in PLOS ONE, a multidisciplinary journal published by the Public Library of Science.
Released: 15-Jan-2021 8:20 AM EST
NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19 Ivermectin is Now a Therapeutic Option for Doctors & Prescribers
Released: 14-Jan-2021 6:05 PM EST
Studying and Treating COVID-19’s Long-Term Impact
Rush University Medical CenterThe CDC is funding a Rush-led effort in which 8 academic medical centers will track the clinical, physical and mental functioning -- including neuro-cognition and fatigue – of nearly 5000 COVID patients for two years to better assess the long-term outcomes of the disease.
Released: 14-Jan-2021 5:20 PM EST
Potential COVID-19 Drug Is Successful in Lab Study
Rush University Medical CenterA new potential therapy for COVID-19 developed by researchers at Rush University Medical Center has shown success in preventing the disease’s symptoms in mice.
Released: 14-Jan-2021 2:40 PM EST
S&T Joins Coalition Seeking to ‘Flush’ out COVID-19 in Wastewater
Homeland Security's Science And Technology DirectorateS&T is working with NIST and the University of Louisville to develop guidelines to standardize Wastewater-Based Epidemiology testing methods nationwide.
Released: 14-Jan-2021 12:40 PM EST
Perceptions of police using PPE during the pandemic
Simon Fraser UniversityA Simon Fraser University study on public perceptions of police officers wearing personal protective equipment (PPE) during the current pandemic finds that most PPE renders positive perceptions of police, while some equipment, including full-face respirator masks, may be viewed more negatively.
Released: 14-Jan-2021 12:05 PM EST
Population density and virus strains will affect how regions can resume normal life
University of Wisconsin-MadisonAs a new, apparently more transmissible version of the virus that causes COVID-19 has appeared in several countries, new research finds that the transmissibility of viral strains and the population density of a region will play big roles in how vaccination campaigns can help towns and cities return to more normal activities. The findings suggest that directing vaccines toward densely populated counties would help to interrupt transmission of the disease.
Showing results
11–20 of 4573
RSS Feeds by Section